Literature DB >> 29256530

Endothelial dysfunction and developmental outcomes of very low birth weight newborns with hypoxic encephalopathy.

Saadat Arif Huseynova1, Nushaba Farkhad Panakhova1, Adila Sabir Hajiyeva2, Pusta Ali Orujova3, Sevinj Nabi Mukhtarova3, Gulnaz Telman Agayeva4.   

Abstract

OBJECTIVE: To investigate the levels of endothelial constricting and dilating mediators in preterm infants with hypoxic-ischaemic encephalopathy and prospectively evaluate the association between levels measured during the perinatal period and the diagnosis of neurodevelopmental disorders at 3 years of age.
METHODS: This regional observational cohort study was conducted at the Azerbaijan Medical University, Baku, Azerbaijan, from November 2011 to January 2013, and comprised very-low-birth-weight infants admitted to the intensive care unit during the perinatal period. Blood concentrations of nitric oxide, endothelin-1 and endothelial nitric oxide synthase were measured on days 1-3 and 5-7 of the neonatal period. Concentrations of neuron-specific enolase and antibodies against N-methyl-D-aspartate glutamate receptors were measured in peripheral blood samples for detection of brain damage in the early neonatal period of life. The infants were divided in 3 different groups: those diagnosed with moderate-to-severe neurodevelopmental disorders or cerebral palsy were included in the first group; those with mild neurologic changes were in the second group; and children without evidence of neurological impairment were in the third group. The fourth group comprised controls. SPSS 20 was used for data analysis.
RESULTS: Of the 62 participants, there were 8(12.9%) in the first group, 20(32.3%) in second, 14(22.6%) in third and 20(32.3%) in the control group. The activity of endothelial nitric oxide synthase was reduced and nitric oxide concentrations were increased in the first group compared to those in the third group (p<0.05). Deep endothelial nitric oxide synthase depression and insufficient endothelin-1 synthesis were associated with diagnosis in the first group (p<0.05). No differences in concentrations of neuron-specific enolase and NR2 antibodies were identified among infants with and without a subsequent diagnosis of neurodevelopmental disorders (p>0.05).
CONCLUSIONS: The association between depressed endothelial nitric oxide synthase activation and insufficient endothelin-1 synthesis in the early days of life of very-low-birth-weight infants might be one of the causes of more serious and irreversible injury of brain tissue.

Entities:  

Keywords:  Perinatal hypoxia, Hypoxic-ischaemic encephalopathy, Endothelial dysfunction, Neurodevelopmental disorders, Cerebral palsy.

Mesh:

Substances:

Year:  2017        PMID: 29256530

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  4 in total

1.  Plasma Levels, Temporal Trends and Clinical Associations between Biomarkers of Inflammation and Vascular Homeostasis after Pediatric Traumatic Brain Injury.

Authors:  Abhijit V Lele; Bhunyawee Alunpipatthanachai; Qian Qiu; Crystalyn Clark-Bell; Arraya Watanitanon; Anne Moore; Randall M Chesnut; William Armstead; Monica S Vavilala
Journal:  Dev Neurosci       Date:  2019-09-25       Impact factor: 2.984

2.  Reduced Intellectual Ability in Offspring Born from Preeclamptic Mothers: A Prospective Cohort Study.

Authors:  Linli Liu; Zhou Lin; Beihong Zheng; Lanlan Wang; Jianqin Zou; Sanshan Wu; Zhongqing Jiang; Qiong Jin; Xuedan Lai; Peihong Lin
Journal:  Risk Manag Healthc Policy       Date:  2020-10-08

3.  Proinflammatory Endothelial Phenotype in Very Preterm Infants: A Pilot Study.

Authors:  Giacomo S Amelio; Livia Provitera; Genny Raffaeli; Ilaria Amodeo; Silvia Gulden; Valeria Cortesi; Francesca Manzoni; Nicola Pesenti; Matteo Tripodi; Valentina Pravatà; Caterina Lonati; Gaia Cervellini; Fabio Mosca; Giacomo Cavallaro
Journal:  Biomedicines       Date:  2022-05-20

4.  An improved formula for standard hypoxia tolerance time (STT) to evaluate hypoxic tolerance in mice.

Authors:  Gang Xu; Yu-Qi Gao; Yi-Xing Gao; Gang Wu; Jian-Yang Zhang; Wen-Xiang Gao
Journal:  Mil Med Res       Date:  2018-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.